Standard BioTools Inc. logo

Standard BioTools Inc.

LAB | NASDAQ
Chart Builder DCF Calculator
$0.74
-$0.03 (-3.87%)
At close: Sep 21, 2026, 4:00 PM ET
$0.73
-$0.01 (-1.35%)
Pre-market: Sep 22, 2026, 4:00 AM ET

Market Data

Market Cap
$301.35M
Enterprise Value
$-158.21M
Beta
1.37
Average Volume
2.98M
Shares Outstanding (Diluted)
390.88M
Shares Change YoY
2.73%
Institutional Ownership
76.57%
Exchange
NASDAQ
ISIN
US34385P1084

Price Performance

Price Change 1M
10.4%
Price Change 3M
-6.6%
Price Change 6M
-23.1%
Price Change YTD
-41.7%
Price Change 1Y
-47.1%
Price Change 3Y
-73.4%
Price Change 5Y
-88.8%
1M CAGR (ann.)
-3.8%
1Y CAGR (ann.)
-43.0%
5Y CAGR (ann.)
-35.3%
All-Time CAGR
-17.0%

Valuation

PE Ratio
-3.22
Forward PE
N/A
PEG Ratio
-0.46
Forward PEG
-0.06
PS Ratio
3.43
Forward PS
3.50
PB Ratio
0.54
P/FCF Ratio
-2.24
P/Adj. FCF Ratio
-1.76
P/OCF Ratio
-3.52
EV/Sales
-1.87
EV/EBIT
1.60
EV/EBITDA
1.72
EV/FCF
1.22
Earnings Yield
-31.1%
FCF Yield
-44.7%
Adj. FCF Yield
-56.7%

Financial Health

Net Cash
$476.42M
Total Debt
$28.09M
Cash & Short-Term Investments
$476.72M
Total Assets
$627.22M
Current Ratio
9.10
Quick Ratio
8.80
Debt / Equity Ratio
0.05
Debt / EBITDA
-0.31
Debt / FCF
-0.22
OCF / Debt
-4.52
Interest Coverage
-5,346.33
Altman Z-Score
-0.02
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
49.1%
Operating Profit Margin
-94.8%
EBITDA Margin
-108.6%
Net Profit Margin
-103.3%
FCF Margin
-153.4%
Adj. FCF Margin
-194.7%
SBC / Revenue
30.9%
SBC Impact (per share)
-27.0%

Returns

Return on Assets
-13.9%
Return on Equity
-18.2%
Return on Invested Capital
-8.3%
Return on Capital Employed
-14.1%
Return on Tangible Assets
-13.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
-7.1%
Revenue CAGR 5Y
-10.6%
Revenue CAGR 10Y
-3.1%
EPS CAGR 3Y
69.9%
EPS CAGR 5Y
48.6%
EPS CAGR 10Y
14.9%
FCF CAGR 3Y
0.4%
FCF CAGR 5Y
-16.8%
FCF CAGR 10Y
-17.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
10
EPS Growth Next 3Y
11.6%
Revenue Growth Next 3Y
1.9%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$0.02
EPS Growth Est (next Q)
-77.8%
Revenue Est (next Q)
$18.8M
Revenue Growth Est (next Q)
-3.9%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$3.25
Price Target Upside
339.2%

Cash Flow

Operating Cash Flow
$-126.9M
Free Cash Flow
$-129.75M
Adj. Free Cash Flow
$-164.73M
FCF Per Share
-$0.21
OCF Per Share
-$0.21
OCF/S Ratio
-94.9%

Income Statement

Revenue
$84.6M
Gross Profit
$41.57M
Operating Income
$-80.2M
EBITDA
$-91.9M
Net Income
$-87.38M
EPS (Diluted)
-$0.23
Revenue / Employee
$218.6K
Profit / Employee
$-225.8K
Employees
387

© 2026 bestshares.com. All rights reserved.